Pilot or pivotal ? [General Sta­tis­tics]

posted by Ohlbe – France, 2018-06-27 14:13 (1419 d 02:15 ago) – Posting: # 18978
Views: 11,207

Dear ElMaestro,

» » OK, maybe if the product has a very low variability and the number of subjects remains very low, it could make sense and save time to directly go for the pivotal. Any experience ?

» Yes absolutely. The majority of dossiers are being accepted without pilot trials.

Sure, when you only have one test formulation. But when you hesitate between two ? Would you directly go for a pivotal where both test formulations would be compared to the reference, and then file whichever one passes ?

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,072 posts in 4,628 threads, 1,565 registered users;
online 23 (0 registered, 23 guests [including 20 identified bots]).
Forum time: Monday 16:28 CEST (Europe/Vienna)

Rules are for the guidance of wise men
and the blind obedience of fools.    attributed to Solon

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5